Well I guess we needed to revisit $50 on our way to $100 ...Nick and Angry-Villa ?
Down 17% , guess I'll buy some .
This Co has a great mgt team and working in very promising areas ....but its early days folks .
Nearest data read out that I'm aware of is Dec 2015 for the PINTA 745 trial .
Baupost added at $42 I believe ...so I'll buy at these levels in the 49's and then may add if we see $42 again
FWP is Forward Pharma ...another Baupost holding ...for the poster asking
Hey Golong ..actually I never wish ill will on anyone on the message boards . Frankly I find YMB pretty good as a sentiment indicator .....when posters are so confident they have it worked out ...time to be careful.
When posters write " having a terrible day " ...time to look at opportunities.
I just bt some ATRA under $50 ...may comment on that board . I like the mgt team and the areas they are working in . Will try and hold to data release near end of year.
Actually , investing can be a very humbling experience ... and todays one of those days.
Well speaking of " No cojones , no glory " ...how are you doing on this "up chuck " kinda day.
Remember the thing about "big positions "....live by the sword , die by it also
Whenever guys are writing posts such as "Free money next stop $100 "...on any stock ... don't walk , run in the opposite direction
Golong ...well since CLDN failed , lets see how well QURE, BLUE and ONCE do tomorrow .
A test of your cojones ? since you like " very large positions "
Golong ...well CLDN's trial failed ...so you dodged a bullet there.....
Golong Whoa ...not for the risk adverse
I already own TTPH and prefer BLUE for my gene therapy play ( instead of QURE ) ....the rest ...cajones my friend .
Re secondary share offering
They did a follow on offering in Feb and raised a net $69.4m .....so doubt if they are doing another one in May !.
I am long the stock ....just don't see anything to push it towards $100 any time soon .
The PEW data ( protein energy wasting ) will be important ...a major concern in my wife's dialysis clinic ...but thats at least 6 mths away .
So until then , whats to drive the stock higher beside the breathless rants by you and Nick ?
Agree that its a small sale .
My pt is that I doubt this is " free money to next stop $100 " as you and Nick surmise .....whats to drive the price higher from here until we see data at end of yr. ?
2010 ...the year that Jesse Livermore reigned supreme on this board ...Yes I owned AMRN in 2010.
A brief history ...from recollection
2010 ...Marine trial shows AMR101 ( now Vascepa ) lowers TG' s without increasing LDL...stock jumps
Late 2010 ..Anchor trial shows shows same ..much larger market so stock hits all time high in early 2011.
CEO ...JZ on CNBC . "..more offers of interest to buy Co then employees "
2011 ...Stock starts tanking due to an ongoing battle over whether AMR101 could be patented .
Jesse Livermore at his finest laid out a very clear explanation on the mis calculation the patent office was making re the Friedwald equation and why AMR101 would eventually be granted a patent .....he was right .
2012 ..AMR101 approved by the FDA for the Marine indication ...mgt immediately unloads shares.
Later in 2012 then CEO JZ and now current CEO John Thero ...unload a ton of shares ....just for "diversification " you understand .....even while touting a buyout was about to happen for "not a $ under $30 "...according to JZ's quote to Bloomberg.
I'll let Swalchie finish the history lesson from here ...he's been around since at least 2012.
My last major purchase was late Oct /early Nov 2014 ...where at 90c a share I made the case that at that price AMRN was a low cost option on an Outcome trial likely to show benefit . Sold half since to recover cost and will hold rest to Interim data
Hi Golong .
ESPR was a triple ...started buying in the 30's ...out of it now.
If ZSPH's long term data comes in as good as we have seen so far with the 10gm dose ......why would anyone want to buy RLYP ( the Co ) ...I can see the argument for owning a position in the stock leading up to FDA approval /earliest to launch etc ...but I don't think anyone is buying the Co until they at least see all the long term data from ZS-9.
Not saying they won't ...just don't expect any action until long term data for both Co's , is known.
What else do you like besides RLYP, ZSPH and CEMP ?
Angry _ Villa
Am I a paid basher ? funny
Nope just looking for some informed opinions whether short or long ...in other words ...looking for signs of intelligent life on this message board .
So far its a lost cause, I'm afraid.
Golong ...actually if you look at our posting history I suggested you look at ESPR on Feb 4th ...at $55 , now at $104.. .....
You are sounding very bullish on ZSPH these days ...what changed ?
Golong ...Thanks for the feedback .
Like I said ...not suggesting you buy ATRA here .
What I do is start small positions in Co's I think are promising ...and wait for either developments in the Co or pull backs caused by events totally unrelated....and then add more .
If I don't at least have some skin in the game, I tend to not follow them
Re possibilities of stock
Well we see its possible to do a " round trip "...:-)
From $12 to $17 and back again .
Bottom line ...data is a long way off ...but if drug helps maintain fistula patency it will be a big deal
Nick ...re "easy no brainer "
Nothing is easy or a no brainer in the stock market ...suggest u learn that before you're permanently separated from what $ you may have .
Guess the " big guys " forgot to chk in with the CEO ....if so he might have told them that he was selling 5,000 shares at around $60 .....well its expensive lining in the Bay Area so hopefully that $300k will hold him over to we at least see P2 data for Pinta 745 by end of yr 2015.
Sentiment on this board is over the top bullish .
This Co has a long way to go .
Any of you even chk out the adverse events for AMG 745 ...now known as Pinta 745 in P1 ?
Hopefully we will see better results in P2.
The deal with Memorial Sloan Kettering is early days ...it ain't $ in the bank yet .....P2 for Pinta 745 is first up.
By the way I'm long the stock ..not because I think they will be at $100 any time soon ...but because of the Mgt talent and financial backing
Hey Golong ....OT
Since we are in the Nephrology space here , you may want to look at ATRA. I have a small position ..its pulling back from its recent run . Its been in the news because of its agreement with Memorial Sloan Kettering to develop a new drug recently granted breakthrough therapy by the FDA.
Its main project tho , currently in P2 , is an IV treatment for dialysis patients to reduce Protein Energy Wasting ( muscle wasting etc )...and may have applications in cancer therapy where again loss of body mass /muscle wasting ...are major concerns . Wife says Protein Energy Wasting ( PEW ) is a major issue in her clinic that current approach's don't treat very well.
Currently the trial is fully enrolled ...primary completion date Oct 2015.
There is some serious brain power ( and financial backing ) behind this Co ...was spun off from Amgen who still own 6% of the stock. Baupost recently upped their position to 20% , Kleiner Perkins are also major holders.
Not saying to buy it here ...just suggest you do some DD on it
Typo ...SRDX should be ADRX . SRDX looks to be doing OK , may have to chk it out
Golong ..no news that I'm aware of .
Held small position in AERI ...just enough to remind me how often small cap biotech blows up on you .
Seem to need to repeatedly learn that lesson ...CLSN, OCUL, SRDX , AERI and now probably CLDN ....nice smacks across my face, to reminding me that they don't all turn into PCYC's and ESPR's
High risk game we are playing here my friend ....depending on your CEMP to bail me out ..:-)